Biondo Investment Advisors’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-19,338
Closed -$6.38M 90
2025
Q4
$6.38M Sell
19,338
-2,720
-12% -$922K 0.77% 38
2025
Q3
$7.62M Buy
22,058
+1,845
+9% +$558K 0.95% 35
2025
Q2
$6.31M Buy
20,213
+971
+5% +$371K 0.83% 40
2025
Q1
$10.1M Buy
19,242
+861
+5% +$440K 1.43% 31
2024
Q4
$9.3M Buy
18,381
+358
+2% +$203K 1.28% 31
2024
Q3
$10.5M Buy
18,023
+367
+2% +$208K 1.44% 26
2024
Q2
$8.99M Buy
17,656
+396
+2% +$194K 1.33% 28
2024
Q1
$8.54M Buy
17,260
+6,911
+67% +$3.51M 1.32% 31
2023
Q4
$5.45M Buy
+10,349
New +$5.52M 0.93% 39

Other funds holding UNH

Biondo Investment Advisors's UNH Position: Q1 2026 in Review

Biondo Investment Advisors sold out of UnitedHealth (UNH) in Q1 2026, closing a stake of 19,338 shares — an estimated $6.38M sold.

Biondo Investment Advisors first reported a position in UNH in Q4 2023 and held it in 9 quarters. The position peaked at $10.5M in Q3 2024. 3,020 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Biondo Investment Advisors reported no remaining UnitedHealth position as of Q1 2026 after selling out during the quarter.
  • Biondo Investment Advisors sold 19,338 UnitedHealth shares in Q1 2026, an estimated $6.38M.
  • Biondo Investment Advisors first reported a position in UnitedHealth in Q4 2023 and held it in 9 quarters.
  • Biondo Investment Advisors's UnitedHealth position peaked at $10.5M in Q3 2024.
  • 3,020 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Biondo Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.